772 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More http://www.zacks.com/stock/news/602683/drug-biotech-stocks-nov-5-earnings-roster-agn-regn-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-602683 Nov 04, 2019 - Let us take a look at five drug/biotech companies, which are supposed to release their quarterly results on Nov 5.
What's in the Cards for Teva (TEVA) This Earnings Season? http://www.zacks.com/stock/news/602734/whats-in-the-cards-for-teva-teva-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-602734 Nov 04, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q3 sales
Bristol-Myers' (BMY) Q3 Earnings & Revenues Beat Estimates http://www.zacks.com/stock/news/596357/bristol-myers-bmy-q3-earnings-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-596357 Oct 31, 2019 - Bristol-Myers (BMY) beats both earnings and sales estimates in the third quarter, primarily on robust sales of Eliquis and Sprycel.
The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG http://www.zacks.com/stock/news/596360/the-zacks-analyst-blog-highlights-alexion-amgen-gilead-and-amag?cid=CS-ZC-FT-press_releases-596360 Oct 31, 2019 - The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG
Biotech Stock Roundup: Q3 Earnings Beat at ALXN & AMGN, Pipeline Updates & More http://www.zacks.com/stock/news/592904/biotech-stock-roundup-q3-earnings-beat-at-alxn-amgn-pipeline-updates-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-592904 Oct 30, 2019 - Key highlights include earnings updates, collaboration deals, and regulatory and pipeline updates.
Amgen Inc (AMGN) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/10/30/amgen-inc-amgn-q3-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 Oct 30, 2019 - AMGN earnings call for the period ending September 30, 2019.
Amgen Inc. (AMGN) CEO Bob Bradway on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4300172-amgen-inc-amgn-ceo-bob-bradway-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Oct 29, 2019 - Amgen Inc. (NASDAQ:AMGN) Q3 2019 Earnings Conference Call October 29, 2019 5:00 PM ET Company Participants Arvind Sood - Vice President, Investor Relations Bob Bradway - Chairman & Chief Executive
Has Amgen (AMGN) Outpaced Other Medical Stocks This Year? http://www.zacks.com/stock/news/590428/has-amgen-amgn-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-590428 Oct 29, 2019 - Is (AMGN) Outperforming Other Medical Stocks This Year?
Is a Beat in Store for Amarin (AMRN) This Earnings Season? http://www.zacks.com/stock/news/590830/is-a-beat-in-store-for-amarin-amrn-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-590830 Oct 29, 2019 - Amarin's (AMRN) third-quarter results are likely to reflect strong demand for its cardiovascular drug, Vascepa.
Pfizer (PFE) Rises on Q3 Earnings & Sales Beat, Ups EPS View http://www.zacks.com/stock/news/590799/pfizer-pfe-rises-on-q3-earnings-sales-beat-ups-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-590799 Oct 29, 2019 - Pfizer (PFE) beats estimates for third-quarter earnings and sales and raises earnings guidance range for 2019 while tightening revenue outlook.

Pages: 12345678...78

<<<Page 3>